News
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...
The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...
Panelists discuss how comprehensive patient education about expected adverse effects, combined with prophylactic measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results